Suppr超能文献

病例报告:肝部分切除联合门静脉结扎取栓术后肿瘤隔离术(CLAPT)治疗伴有门静脉癌栓的晚期肝细胞癌

Case Report: Combining liver partition and portal vein ligation after thrombectomy for tumor isolation (CLAPT) to treat advanced hepatocellular carcinoma with portal vein tumor thrombosis.

作者信息

Jin Zongrui, Wu Guolin, Xu Banghao, Wang Jilong, Zhu Hai, Guo Ya, Peng Minhao, Peng Tao, Wen Zhang

机构信息

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Surg. 2022 Sep 13;9:928452. doi: 10.3389/fsurg.2022.928452. eCollection 2022.

Abstract

BACKGROUND

Primary liver cancer is the third leading cause of cancer-related deaths worldwide in 2020, and hepatocellular carcinoma (HCC) is the major pathological type. Patients with HCC complicated with portal vein tumor thrombosis (PVTT) have a poor prognosis, and controversies regarding treatment options exist among international scholars. Patients with VP4 or Cheng's type III classification are generally considered ineligible for surgical treatment.

METHODS

We retrospectively analyzed three cases of HCC with PVTT who underwent a novel modified surgical procedure. The procedure included portal vein thrombectomy and portal vein ligation with liver parenchymal separation for the resection of the tumor thrombus involving the main portal vein trunk and for the isolation of the giant tumor. The three cases were then treated with targeted drugs postoperatively.

RESULTS

One case developed acute renal failure in the perioperative period, and the renal function gradually recovered after the treatment. The two remaining cases recovered uneventfully postoperatively. The prognosis of the three patients was encouraging. Only one patient died of lung metastasis after 13 months, and the remaining patients were still alive after 41 and 21 months, respectively.

CONCLUSIONS

We provide a new possible surgical option for patients with advanced HCC with PVTT. The surgical procedure was inspired by associating liver partition with portal vein ligation for staged hepatectomy and portal vein thrombectomy. The survival time was significantly prolonged after the patients underwent thrombectomy, tumor isolation, and postoperative nonsurgical treatment. Hence, the combination of liver partition and portal vein ligation after thrombectomy for tumor isolation has the potential for the treatment of advanced HCC with PVTT.

摘要

背景

原发性肝癌是2020年全球癌症相关死亡的第三大主要原因,肝细胞癌(HCC)是主要的病理类型。HCC合并门静脉癌栓(PVTT)的患者预后较差,国际学者对于治疗方案存在争议。VP4型或程氏III型分类的患者通常被认为不适合手术治疗。

方法

我们回顾性分析了3例接受新型改良手术的HCC合并PVTT患者。该手术包括门静脉血栓切除术和门静脉结扎联合肝实质离断,用于切除累及门静脉主干的肿瘤血栓以及分离巨大肿瘤。这3例患者术后均接受了靶向药物治疗。

结果

1例患者在围手术期发生急性肾衰竭,治疗后肾功能逐渐恢复。其余2例患者术后恢复顺利。3例患者的预后令人鼓舞。仅1例患者在13个月后死于肺转移,其余患者分别在41个月和21个月后仍存活。

结论

我们为晚期HCC合并PVTT患者提供了一种新的可能的手术选择。该手术方法的灵感来自于将肝实质离断与门静脉结扎用于分期肝切除术和门静脉血栓切除术。患者接受血栓切除、肿瘤分离及术后非手术治疗后生存时间显著延长。因此,血栓切除术后肝实质离断与门静脉结扎联合用于肿瘤分离有可能用于治疗晚期HCC合并PVTT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd44/9513360/788070795990/fsurg-09-928452-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验